Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Are psychedelics the heroes or villains?

Corina Fratila, MD
Meds
May 13, 2022
Share
Tweet
Share

Like many fellow Americans, I had my first psychedelic experience in the middle of the pandemic, in a place where the use of psychedelics is decriminalized.

I grew up in a Communist country, and the ban and stigma against psychedelics were tremendous. There was no plant medicine available, and I didn’t know even one person using anything other than alcohol and prescription drugs.

I read Michael Pollan’s book How to Change Your Mind about five years ago and read all the articles in the New York Times about the benefits of psychedelics for mental health. I was intrigued. I didn’t know what to expect; everybody’s descriptions were vague and hard to grasp. I needed a lived experience.

So, with the help of one of my mentors, at the ripe age of 48 years old, I had my first psychedelic experience. It was truly beautiful. All I did was stare into my mentor’s eyes for a few hours, and had incredible visuals. Everything I knew looked different, and I saw the world with whole new eyes like I was a child again.

The smallest details of the world were incredibly beautiful and meaningful.

That is all to say that my interest was ignited to the point that I have enrolled in the Synthesis program, a Netherlands- based training program to become a psychedelic guide. I wanted to learn everything and anything there was to learn about these magic substances and their effects on the brain, behavior, and mental health. It became obvious to me why psychedelics would be associated with the remission of depression. A sense of wonder and awe, a renewed interest in the natural world, and a sense of the interconnectedness of all humans and sentient beings could definitely account for lifting the heaviest of depressions.

During my year-long training, I made many wonderful connections, and I did get to know people who have been doing underground work with plant medicine for many years. I learned so many new things, unconventional treatment modalities, and points of view.

At the end of my training, one of the people I met asked me if I wanted to be an assistant facilitator for a group ceremony inside one of the psychedelic churches.

The experience was truly remarkable. I have witnessed a seasoned facilitator at work, a psychology professor turned shaman, interject himself into the psyche of the 12 people in the group making the journey. I have witnessed him spooning people in an altered state. I was confused and perplexed. As a physician, I have abided by a very strict code of ethics in my 20+ years of practice, and this was a very unusual practice.

The way I see it, is that the patients/clients/churchgoers are in an extremely vulnerable state when they are under the influence of plant medicine. Not only is there extreme vulnerability, but this is a highly impressionable state. It is almost like imprinting: You know the story with the little ducklings hatching out of eggs. If the first thing they see when they hatch is a robot or a human, they get imprinted with that person, or robot, or cat, and then they believe that that particular robot or human or cat is their mother. The awakening from the psychedelic state is very similar to that impressionable state of a new hatchling.

The mental health crisis in the world and the United States is huge right now, and many people will look for underground practitioners since plant medicine has not been legalized yet.

Another one of the reasons I did the training and the reasons I wanted to learn everything I could about psychedelics, was to make sure that I am a resource for the young people, possibly the most vulnerable of all, other than patients with mental health issues. I have young children, and I don’t think the old way of asking them to stay away from “drugs” will work in this new world we are entering. I think being an informed parent and a resource of information and wisdom will function much better than imposing restrictions and inhibiting the use of substances.

Psychedelics are, as their name says, mind-revealing. They are non-specific amplifiers.

ADVERTISEMENT

If we are frightened of them, we are frightened of our own depth, and that is something worth examining.

Corina Fratila is an endocrinologist.

Image credit: Shutterstock.com

Prev

We are warriors: doctors and patients

May 13, 2022 Kevin 0
…
Next

A specific way to improve our health care delivery system

May 13, 2022 Kevin 0
…

Tagged as: Psychiatry

Post navigation

< Previous Post
We are warriors: doctors and patients
Next Post >
A specific way to improve our health care delivery system

ADVERTISEMENT

More by Corina Fratila, MD

  • No wonder patients detest our health care system, and doctors are leaving medicine in droves

    Corina Fratila, MD
  • Are physicians the stewards of healing that they are meant to be? 

    Corina Fratila, MD

Related Posts

  • Social workers are medicine’s unsung heroes

    Richard Gunderman, MD, PhD
  • The life cycle of medication consumption

    Fery Pashang, PharmD
  • The abundant and colorful world of pharmaceuticals

    Fery Pashang, PharmD
  • Colorful pills don’t paint my world

    Fery Pashang, PharmD
  • The ritual of taking medications: the pill wheel

    Fery Pashang, PharmD
  • 4280: the number of pills Bob took last year

    Fery Pashang, PharmD

More in Meds

  • FDA delays could end vital treatment for rare disease patients

    G. van Londen, MD
  • Pharmacists are key to expanding Medicaid access to digital therapeutics

    Amanda Matter
  • How medicine repurposing enables value-based pain management and insomnia therapy

    Olumuyiwa Bamgbade, MD
  • Forced voicemail and diagnosis codes are endangering patient access to medications

    Arthur Lazarus, MD, MBA
  • From stigma to science: Rethinking the U.S. drug scheduling system

    Artin Asadipooya
  • How drugmakers manipulate your health from diagnosis to prescription

    Martha Rosenberg
  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI is already replacing doctors—just not how you think

      Bhargav Raman, MD, MBA | Tech

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why timing, not surgery, determines patient survival

      Michael Karch, MD | Conditions
    • Why health care leaders fail at execution—and how to fix it

      Dave Cummings, RN | Policy
    • How digital tools are reshaping the doctor-patient relationship

      Vineet Vishwanath | Tech
  • Past 6 Months

    • Forced voicemail and diagnosis codes are endangering patient access to medications

      Arthur Lazarus, MD, MBA | Meds
    • How President Biden’s cognitive health shapes political and legal trust

      Muhamad Aly Rifai, MD | Conditions
    • Why are medical students turning away from primary care? [PODCAST]

      The Podcast by KevinMD | Podcast
    • The One Big Beautiful Bill and the fragile heart of rural health care

      Holland Haynie, MD | Policy
    • Why “do no harm” might be harming modern medicine

      Sabooh S. Mubbashar, MD | Physician
    • The hidden health risks in the One Big Beautiful Bill Act

      Trevor Lyford, MPH | Policy
  • Recent Posts

    • Facing terminal cancer as a doctor and mother

      Kelly Curtin-Hallinan, DO | Conditions
    • Online eye exams spark legal battle over health care access

      Joshua Windham, JD and Daryl James | Policy
    • FDA delays could end vital treatment for rare disease patients

      G. van Londen, MD | Meds
    • Pharmacists are key to expanding Medicaid access to digital therapeutics

      Amanda Matter | Meds
    • Why ADHD in women requires a new approach [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI is already replacing doctors—just not how you think

      Bhargav Raman, MD, MBA | Tech

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...